Drug Pricing Policy Could Surface At Becerra’s Confirmation Hearing As Biden’s Health Team Takes Shape

By John Wilkerson / February 22, 2021 at 3:35 PM
The Senate Finance Committee on Wednesday (Feb. 24) will hold a confirmation hearing for HHS Secretary-nominee Xavier Becerra, and the California attorney general will likely be asked about at least some of the drug pricing policies he supports, including his desire to investigate rebate walls, to stop drug makers from blocking 340B discounts, to break drug patents and to ban pay-for-delay settlements. Becerra would head a health care team that, if all works as the president plans, would include Chiquita...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.